Bon ap­petit: Cel­lec­tis CEO Chouli­ka hosts a gene-edit­ed feast; CRO Med­pace adding 650 staffers

Cel­lec­tis CEO An­dré Chouli­ka loves noth­ing bet­ter than cel­e­brat­ing the pi­o­neer­ing work he’s plan­ning to do with gene edit­ing and next-gen CAR-T. But he al­so …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.